Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 599
Quick answer
599 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7267978
Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression
granted -
US 7268222
Polynucleotides encoding human transporter proteins
granted -
US 7268148
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
granted -
US 7268122
Use of oversulfated polysaccharides as inhibitors of HIV
granted -
US 7268232
Androgen receptor modulators and method of treating disease using the same
granted -
US 7267823
Ebola peptides and immunogenic compositions containing same
granted -
US 7267941
Cyanovirin variant-polymer conjugates
granted -
US 7271150
Modified growth hormone
granted -
US 7271186
Nanomolar β-lactamase inhibitors
granted -
US 7270960
Diagnosis of ovarian carcinomas
granted -
US 7271181
Inhibitors of p38
granted -
US 7271179
Inhibitors of JAK protein kinase
granted -
US 7270994
Lactobacillus casei Bd-II stain and used to reduce blood cholesterol
granted -
US 7271148
Inhibition of cellular proteases
granted -
US 7271182
Salts of benzimidazole compound and use thereof
granted -
US 7271161
Platinum complexes as antitumor agents in combination with biochemical modulation
granted -
WO 2007104583
COMPRIMÉ SÉCABLE AVEC PRÉCISION
granted -
US 7273923
Zinc finger proteins for DNA binding and gene regulation in plants
granted -
US 7273851
Tri-peptide hepatitis C serine protease inhibitors
granted -
US 7273369
Curing light
granted -
US 7273713
Methods of modulating mitochondrial NAD-dependent deacetylase
granted -
US 7273613
Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
granted -
US 7273710
Method for screening MCH receptor antagonist/agonist
granted -
US 7273857
Benzimidazolidinone derivatives as muscarinic agents
granted -
US 7273853
6-11 bicyclic ketolide derivatives
granted -
US 7273885
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7276352
Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor
granted -
US 7276527
5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
granted -
US 7276502
Thiazoles useful as inhibitors of protein kinases
granted -
US 7276629
Hydrogenation of imine intermediates of sertraline with catalysts
granted -
US 7276348
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
granted -
US 7276643
Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents
granted -
US 7276227
Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
granted -
US 7279163
Water-in-oil emulsion vaccines
granted -
US 7279320
Curlicue vaccine strain of Bacillus anthracis
granted -
US 7279469
Diaminotriazoles useful as inhibitors of protein kinases
granted -
US 7279159
VEGF inhibitor polypeptides
granted -
US 7279294
Tumor markers in ovarian cancer
granted -
US 7279306
Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
granted -
US 7279326
Composition for delivery of a mitochondrial genome to a cell
granted -
US 7279322
Electrospraying apparatus and method for coating particles
granted -
US 7279458
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7279466
Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof
granted -
US 7279571
Methods of preparing pimecrolimus
granted -
US 7279476
Pyrazole-derived kinase inhibitors and uses thereof
granted -
US 7282482
NGF for the prevention of demyelination in the nervous system
granted -
US 7282563
Opioid receptors and methods of use
granted -
US 7282206
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
granted
Frequently asked questions
How many pharma patents expire in 2027?
599 published patents in our USPTO index have expiration dates falling in calendar year 2027.